✦ LIBER ✦

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled study

✍ Scribed by Patrict M. Plenger; C.Edward Dixon; Rosario M. Castillo; Ralph F. Frankowski; Stuart A. Yablon; Harvey S. Levin

Book ID: 117044977
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 628 KB
Volume: 77
Category: Article
ISSN: 1532-821X
DOI: 10.1016/s0003-9993(96)90291-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Montelukast treatment of moderate to sev

Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial

✍ Niels K. Veien; Michael Busch-Sørensen; Birgitte Stausbøl-Grøn 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Efficacy of rotigotine for treatment of

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

✍ Claudia Trenkwalder; Heike Beneš; Werner Poewe; Wolfgang H Oertel; Diego Garcia- 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 213 KB

Moderate to severe plaque psoriasis with

Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanercept

✍ Jerry Bagel; Charles Lynde; Stephen Tyring; Gregory Kricorian; Yifei Shi; Paul K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 354 KB

486 A DOUBLE BLIND RANDOMISED CONTROLLED

486 A DOUBLE BLIND RANDOMISED CONTROLLED CROSSOVER TRIAL COMPARING AMITRIPTYLINE AND PLACEBO FOR THE TREATMENT OF MODERATE TO SEVERE HIV NEUROPATHY

✍ N. Dinat; N. Hatta 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 64 KB

Fontolizumab in moderate to severe Crohn

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

✍ Walter Reinisch; Williem de Villiers; László Bene; László Simon; István Rácz; Se 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Background: The safety and efficacy of fontolizumab, a humanized anti-interferon gamma antibody, was investigated in patients with Crohn's disease (CD). Elevated gut mucosal levels of interferon gamma, a key cytokine involved in the inflammatory process of CD, are associated with disease symptom

Adalimumab for the treatment of patients

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views